Your session is about to expire
← Back to Search
Post-operative Adaptive Radiation Therapy for Prostate Cancer
N/A
Waitlist Available
Led By Charles N Catton, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
Study Summary
This trial will study the side effects of radiation therapy for prostate cancer by asking 20 subjects to fill out surveys about their quality of life and toxicity scores.
Eligible Conditions
- Prostate Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in radiation dose delivered to target volumes and normal tissue
Secondary outcome measures
Time for radiotherapy replanning
Toxicity associated with the adaptive radiotherapy technique.
Volumetric modulated arc therapy impact in a clinical adaptive Radiotherapy workflow.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Post-Operative adaptive radiotherapyExperimental Treatment1 Intervention
All Patients enrolled in this study will have additional scans (Cone-Beam CT, MRI) daily during their treatment. This extra imaging will help us see any changes that might have occurred during radiation treatment and update the treatment plan to include these changes before patient treatment is continued.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Post-operative Adaptive Radiation Therapy
2013
N/A
~30
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,468 Previous Clinical Trials
484,498 Total Patients Enrolled
63 Trials studying Prostate Cancer
15,379 Patients Enrolled for Prostate Cancer
Charles N Catton, MDPrincipal InvestigatorThe Princess Margaret Cancer Foundation
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a condition called inflammatory bowel disease or other reasons that make it unsafe for you to receive radiotherapy.You are scheduled to receive radiation therapy to your pelvic lymph nodes.You have an artificial hip.You have received radiation therapy to your pelvic area in the past.
Research Study Groups:
This trial has the following groups:- Group 1: Post-Operative adaptive radiotherapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available openings in this research project?
"This experimental study, which was initially launched on July 1st 2013 and edited as recently as October 20th 2022, is not currently accepting participants. Nonetheless, 1321 other trials are recruiting at this time according to clinicaltrials.gov records."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger